BofA's Buy Rating on IBM#
BofA Securities has reiterated its Buy rating on International Business Machines (IBM) stock, maintaining a price target of $300. The firm believes that IBM is currently undervalued, with a price-to-earnings (P/E) ratio of 22.4 and a favorable price/earnings to growth (PEG) ratio of 0.31, indicating potential for future growth relative to its earnings.
Recent Earnings Performance#
In its first-quarter results, IBM reported revenue that slightly exceeded expectations, along with earnings per share (EPS) that were $0.10 higher than analysts had predicted. This positive performance was attributed to reduced selling, general, and administrative expenses, along with a $0.09 boost from other income and expenses. However, the company’s guidance for second-quarter pretax income indicated a smaller increase than analysts had anticipated.
Future Growth Prospects#
IBM has slightly raised its software growth outlook to above 10%, despite the early completion of its Confluent acquisition. BofA estimates that this acquisition will contribute about 1% to IBM’s growth in the future. The firm noted that IBM may explore additional mergers and acquisitions later this year, taking advantage of attractive software valuations, although the immediate focus will be on integrating Confluent.
Financial Strength and Dividend History#
BofA's continued Buy rating is supported by IBM's transition towards higher-margin software, robust free cash flow, and opportunities in quantum computing. The company also boasts a 2.67% dividend yield and has a remarkable 30-year history of increasing its dividends. This financial stability underscores IBM’s strong position in the market, making it a company to watch in the coming quarters.